0001108205-24-000050.txt : 20240523 0001108205-24-000050.hdr.sgml : 20240523 20240523160858 ACCESSION NUMBER: 0001108205-24-000050 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240521 FILED AS OF DATE: 20240523 DATE AS OF CHANGE: 20240523 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Borgman Anne Elizabeth CENTRAL INDEX KEY: 0001886388 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30347 FILM NUMBER: 24978254 MAIL ADDRESS: STREET 1: 9000 VIRGINIA MANOR ROAD STREET 2: SUITE 200 CITY: BELTSVILLE STATE: MD ZIP: 20705 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CURIS INC CENTRAL INDEX KEY: 0001108205 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 043505116 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 128 SPRING STREET STREET 2: BUILDING C, SUITE 500 CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 617-503-6500 MAIL ADDRESS: STREET 1: 128 SPRING STREET STREET 2: BUILDING C, SUITE 500 CITY: LEXINGTON STATE: MA ZIP: 02421 4 1 wk-form4_1716494923.xml FORM 4 X0508 4 2024-05-21 0 0001108205 CURIS INC CRIS 0001886388 Borgman Anne Elizabeth 128 SPRING STREET BUILDING C - SUITE 500 LEXINGTON MA 02421 1 0 0 0 0 Non Qualified Stock Option 11.62 2024-05-21 4 A 0 4250 11.62 A 2034-01-19 Common Stock 4250 4250 D This option grant, as disclosed in Curis Inc.'s 2024 proxy statement, was approved by the Board of Directors of Curis, Inc. on January 20, 2024, contingent upon shareholder approval of Curis's Fifth Amended and Restated 2010 Stock Incentive Plan to increase the number of shares authorized for issuance thereunder; and further provided that such option would not be exercisable and no common stock would be issued thereunder, if the Fifth Amended and Restated 2010 Plan was not approved by Curis's shareholders. On May 21, 2024, at the 2024 annual meeting of shareholders, Curis's shareholders approved the Fifth Amended and Restated 2010 Plan. The option grant described in this Form 4 filing vests as to 100% of the underlying shares on January 20, 2025. /s/ Diantha Duvall, Attorney-in-fact 2024-05-23